Symbols / OSRH
OSRH Chart
About
OSR Holdings, Inc., a healthcare holding company, develops a portfolio of therapies and healthcare solutions in the United States, Switzerland, and South Korea. The company develops immunotherapy products, including VXM01, an immuno-oncology candidate for glioblastoma that is in phase 2 clinical trial, as well as preclinical stage products, such as VXM04 to treat mesothelin; VXM06 for the treatment of Wilms Tumor Protein (WT1); VXM08 for Carcinoembryonic antigen (CEA); and VXM10 for PD-L1. It is also developing design-augmented (DA) biologics comprising DRT-102, a clinical-stage asset for spinal fusion; and DRT-101, a pre-clinical stage asset for osteoarthritis. In addition, the company distributes neurovascular intervention medical device and systems. OSR Holdings, Inc. is based in Bellevue, Washington.
Fundamentals
Scroll to Statements| Sector | Healthcare | Industry | Biotechnology | Market Cap | 11.09M |
| Enterprise Value | 65.51M | Income | -6.61M | Sales | -90.52K |
| Book/sh | 3.46 | Cash/sh | 0.09 | Dividend Yield | — |
| Payout | 0.00% | Employees | 19 | IPO | — |
| P/E | — | Forward P/E | — | PEG | — |
| P/S | -122.53 | P/B | 0.12 | P/C | — |
| EV/EBITDA | 18.70 | EV/Sales | -723.71 | Quick Ratio | 0.18 |
| Current Ratio | 0.21 | Debt/Eq | 3.27 | LT Debt/Eq | — |
| EPS (ttm) | -0.28 | EPS next Y | — | EPS Growth | — |
| Revenue Growth | -23.70% | Earnings | — | ROA | -1.80% |
| ROE | -8.95% | ROIC | — | Gross Margin | 0.00% |
| Oper. Margin | -6.06% | Profit Margin | 0.00% | Shs Outstand | 25.67M |
| Shs Float | 7.85M | Short Float | 3.61% | Short Ratio | 0.16 |
| Short Interest | — | 52W High | 10.00 | 52W Low | 0.42 |
| Beta | 1.41 | Avg Volume | 4.91M | Volume | 361.89K |
| Target Price | $10.00 | Recom | None | Prev Close | $0.41 |
| Price | $0.43 | Change | 5.08% |
Valuation Models
Price estimates from analyst targets and simple models.
1. Analyst consensus
$10.00
Mean price target
2. Current target
$0.43
Latest analyst target
3. DCF / Fair value
$3.74
Simplified: (Free Cash Flow ÷ Shares) × 18 (P/FCF multiple). Not a …
Ratings
Current target
$0.43
Low
$10.00
High
$10.00
Mean
$10.00
- OSR CEO plots $815M VXM01 deal and wearable-device merger bet - Stock Titan Mon, 02 Feb 2026 08
- OSR Holdings Provides Strategic Update on Woori IO Term Sheet and Share Exchange Structure - PR Newswire Wed, 30 Jul 2025 07
- OSR Holdings stock soars after Vaximm enters licensing term sheet - Investing.com Fri, 21 Nov 2025 08
- OSR Holdings Completes Woori IO Acquisition, Secures Long-Term Shareholder Alignment, and Reviews Strategic Combination of Medical Device Subsidiaries - Newswire.com ue, 27 Jan 2026 08
- Emerging Growth Research Initiates Coverage on OSR Holdings, Inc. with a Buy-Emerging Rating and $10.00 Price Target - TMX Newsfile Mon, 20 Oct 2025 07
- 12 Health Care Stocks Moving In Monday's After-Market Session - Sahm ue, 03 Feb 2026 08
- OSR Holdings, Inc. (OSRH) Stock: Jumps 27% Amid Vaximm AG's Strategic Licensing Agreement - CoinCentral Fri, 21 Nov 2025 08
- Below $1: OSR Holdings Faces Nasdaq Compliance Challenge While Investigating Unusual Trading Patterns - Stock Titan ue, 09 Sep 2025 07
- OSR Holdings Major Leap: What’s Ahead? - StocksToTrade Mon, 25 Aug 2025 07
- Is OSRH stock showing strong momentum - Insider Selling & Community Verified Swing Trade Signals - mfd.ru Sun, 15 Feb 2026 01
- 12 Health Care Stocks Moving In Friday's After-Market Session - Benzinga Fri, 30 Jan 2026 08
- OSR Holdings Enters into Term Sheet to Acquire Woori IO, a Pioneer in Noninvasive Glucose Monitoring Technology - PR Newswire hu, 24 Jul 2025 07
- How OSRH stock reacts to oil prices - Weekly Trade Review & Proven Capital Preservation Tips - mfd.ru Sat, 14 Feb 2026 14
- OSR unit Vaximm enters term sheet for potential cancer therapy license - Investing.com Fri, 21 Nov 2025 08
- OSR Holdings Receives Nasdaq Minimum Bid Price Deficiency Notice; Company Highlights Unusual Trading Activity - PR Newswire ue, 09 Sep 2025 07
Insider Transactions
No recent insider transactions.
Financials
| Line Item | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|
| TaxEffectOfUnusualItems | 0.00 | 0.00 | 0.00 |
| TaxRateForCalcs | 0.21 | 0.21 | 0.00 |
| NormalizedEBITDA | -2.07M | 944.59K | -590.92K |
| TotalUnusualItems | -413.54K | 1.69M | |
| TotalUnusualItemsExcludingGoodwill | -413.54K | 1.69M | |
| NetIncomeFromContinuingOperationNetMinorityInterest | -2.41M | 403.78K | 1.06M |
| ReconciledDepreciation | 9.71M | 23.25K | |
| ReconciledCostOfRevenue | 2.52M | 0.00 | |
| EBITDA | -2.07M | 944.59K | 1.10M |
| EBIT | -2.07M | 944.59K | 1.08M |
| NetInterestIncome | 1.41M | 2.78M | -12.27K |
| InterestExpense | 43.01K | 0.00 | 14.22K |
| InterestIncome | 1.45M | 2.78M | 1.96K |
| NormalizedIncome | -2.41M | 403.78K | -628.40K |
| NetIncomeFromContinuingAndDiscontinuedOperation | -2.41M | 403.78K | 1.06M |
| TotalExpenses | 3.52M | 1.83M | 621.32K |
| RentExpenseSupplemental | 22.99K | 329.08 | |
| TotalOperatingIncomeAsReported | -3.52M | -1.83M | -621.32K |
| DilutedAverageShares | 19.28M | 2.15M | 2.15M |
| BasicAverageShares | 19.28M | 2.15M | 2.15M |
| DilutedEPS | -0.13 | 0.19 | 0.49 |
| BasicEPS | -0.13 | 0.19 | 0.49 |
| DilutedNIAvailtoComStockholders | -2.41M | 403.78K | 1.06M |
| NetIncomeCommonStockholders | -2.41M | 403.78K | 1.06M |
| NetIncome | -2.41M | 403.78K | 1.06M |
| MinorityInterests | 0.00 | 0.00 | |
| NetIncomeIncludingNoncontrollingInterests | -2.41M | 403.78K | 1.06M |
| NetIncomeContinuousOperations | -2.41M | 403.78K | 1.06M |
| TaxProvision | 295.73K | 540.81K | 0.00 |
| PretaxIncome | -2.12M | 944.59K | 1.06M |
| OtherIncomeExpense | -406.96K | 1.70M | |
| OtherNonOperatingIncomeExpenses | 6.58K | 5.19K | |
| SpecialIncomeCharges | -311.17K | 1.75M | |
| GainOnSaleOfPPE | 1.06K | 1.83M | |
| WriteOff | 0.00 | 77.39K | |
| ImpairmentOfCapitalAssets | 312.22K | 0.00 | |
| GainOnSaleOfSecurity | -102.37K | -55.33K | |
| NetNonOperatingInterestIncomeExpense | 1.41M | 2.78M | -12.27K |
| InterestExpenseNonOperating | 43.01K | 0.00 | 14.22K |
| InterestIncomeNonOperating | 1.45M | 2.78M | 1.96K |
| OperatingIncome | -3.52M | -1.83M | -621.32K |
| OperatingExpense | 3.52M | 1.83M | 621.32K |
| OtherOperatingExpenses | 22.74K | 4.47K | |
| OtherTaxes | 21.53K | 8.88K | |
| ProvisionForDoubtfulAccounts | 35.30K | 0.00 | |
| DepreciationAmortizationDepletionIncomeStatement | 9.70M | 23.25K | |
| DepreciationAndAmortizationInIncomeStatement | 9.70M | 23.25K | |
| Amortization | 9.55M | 0.00 | |
| AmortizationOfIntangiblesIncomeStatement | 9.55M | 0.00 | |
| DepreciationIncomeStatement | 144.35K | 23.25K | |
| ResearchAndDevelopment | 251.10K | 0.00 | |
| SellingGeneralAndAdministration | 3.52M | 1.83M | 584.72K |
| SellingAndMarketingExpense | 6.93K | 0.00 | |
| GeneralAndAdministrativeExpense | 3.52M | 1.83M | 584.72K |
| OtherGandA | 3.52M | 1.83M | 182.04K |
| InsuranceAndClaims | 20.86K | 1.08K | |
| RentAndLandingFees | 22.99K | 329.08 | |
| SalariesAndWages | 1.04M | 401.27K | |
| GrossProfit | 921.41K | 0.00 | |
| CostOfRevenue | 2.53M | 0.00 | |
| TotalRevenue | 0.00 | 0.00 | 0.00 |
| OperatingRevenue | 0.00 | 0.00 | 0.00 |
| Line Item | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|
| OrdinarySharesNumber | 19.28M | 19.28M | 19.28M |
| ShareIssued | 19.28M | 19.28M | 19.28M |
| NetDebt | 2.50M | 263.46M | |
| TotalDebt | 2.56M | 1.17B | 1.56M |
| TangibleBookValue | -6.49M | 32.52M | -16.62M |
| InvestedCapital | -3.92M | 32.52M | 100.36M |
| WorkingCapital | -6.26M | -2.02M | -1.44M |
| NetTangibleAssets | -6.49M | 32.52M | -16.62M |
| CapitalLeaseObligations | 207.49M | 296.49K | |
| CommonStockEquity | -6.49M | 32.52M | 99.10M |
| TotalCapitalization | -6.49M | 32.52M | 99.23M |
| TotalEquityGrossMinorityInterest | -6.49M | 32.52M | 99.10M |
| MinorityInterest | 0.00 | 0.00 | |
| StockholdersEquity | -6.49M | 32.52M | 99.10M |
| GainsLossesNotAffectingRetainedEarnings | 168.94M | 0.00 | |
| OtherEquityAdjustments | 168.94M | ||
| RetainedEarnings | -8.33M | -3.91M | 53.11K |
| AdditionalPaidInCapital | 0.00 | 0.00 | 94.45M |
| CapitalStock | 1.85M | 36.43M | 4.60M |
| CommonStock | 1.85M | 36.43M | 4.60M |
| PreferredStock | 0.00 | 0.00 | |
| TotalLiabilitiesNetMinorityInterest | 8.79M | 4.11M | 21.66M |
| TotalNonCurrentLiabilitiesNetMinorityInterest | 2.07M | 2.07M | 15.80M |
| EmployeeBenefits | 2.44M | 0.00 | |
| NonCurrentPensionAndOtherPostretirementBenefitPlans | 2.44M | 0.00 | |
| NonCurrentDeferredLiabilities | 2.07M | 2.07M | 15.42M |
| NonCurrentDeferredTaxesLiabilities | 43.33B | 15.42M | |
| LongTermDebtAndCapitalLeaseObligation | 561.66M | 373.69K | |
| LongTermCapitalLeaseObligation | 101.66M | 247.00K | |
| LongTermDebt | 460.00M | 126.69K | |
| CurrentLiabilities | 6.72M | 2.04M | 5.86M |
| OtherCurrentLiabilities | 78.34M | 90.67K | |
| CurrentDebtAndCapitalLeaseObligation | 2.56M | 605.83M | 1.19M |
| CurrentCapitalLeaseObligation | 105.83M | 49.50K | |
| CurrentDebt | 2.56M | 500.00M | 1.14M |
| OtherCurrentBorrowings | 800.00K | 500.00M | 913.26K |
| LineOfCredit | 0.00 | 224.28K | |
| CurrentNotesPayable | 1.76M | 0.00 | |
| PensionandOtherPostRetirementBenefitPlansCurrent | 27.80M | 14.30K | |
| PayablesAndAccruedExpenses | 4.16M | 2.04M | 4.57M |
| CurrentAccruedExpenses | 558.55M | 308.59K | |
| Payables | 4.16M | 2.04M | 4.26M |
| DuetoRelatedPartiesCurrent | 72.00K | 72.00K | |
| TotalTaxPayable | 1.20M | 884.52K | 4.27K |
| IncomeTaxPayable | 358.33K | 524.56K | 4.27K |
| AccountsPayable | 2.88M | 1.08M | 4.26M |
| TotalAssets | 2.30M | 36.63M | 120.76M |
| TotalNonCurrentAssets | 1.85M | 36.61M | 116.34M |
| OtherNonCurrentAssets | 1.85M | 36.61M | 1.02 |
| NonCurrentDeferredAssets | 107.39M | 25.44K | |
| NonCurrentDeferredTaxesAssets | 107.39M | 25.44K | |
| NonCurrentNoteReceivables | 440.42M | 218.50K | |
| InvestmentsAndAdvances | 7.95M | 5.29K | |
| InvestmentinFinancialAssets | 7.95M | 5.29K | |
| AvailableForSaleSecurities | 7.95M | 5.29K | |
| GoodwillAndOtherIntangibleAssets | 278.37B | 115.72M | |
| OtherIntangibleAssets | 230.85B | 103.59M | |
| Goodwill | 47.52B | 12.13M | |
| NetPPE | 235.44M | 371.60K | |
| AccumulatedDepreciation | -662.54M | -184.43K | |
| GrossPPE | 897.98M | 556.03K | |
| ConstructionInProgress | 34.92M | 52.83K | |
| OtherProperties | 33.35M | ||
| MachineryFurnitureEquipment | 500.90M | 210.98K | |
| BuildingsAndImprovements | 328.81M | 292.23K | |
| Properties | 0.00 | 0.00 | |
| CurrentAssets | 455.40K | 22.63K | 4.42M |
| OtherCurrentAssets | 89.26K | 7.21K | |
| PrepaidAssets | 160.28M | 16.32K | |
| Inventory | 1.80B | 1.08M | |
| FinishedGoods | 1.80B | 1.08M | |
| Receivables | 300.00K | 0.00 | 505.97K |
| OtherReceivables | 68.14M | 122.06K | |
| DuefromRelatedPartiesCurrent | 300.00K | 0.00 | |
| TaxesReceivable | 6.71M | 11.50K | |
| LoansReceivable | 0.00 | ||
| AccountsReceivable | 1.48B | 372.40K | |
| AllowanceForDoubtfulAccountsReceivable | -45.49M | 0.00 | |
| GrossAccountsReceivable | 1.52B | 372.40K | |
| CashCashEquivalentsAndShortTermInvestments | 66.14K | 15.42K | 2.82M |
| OtherShortTermInvestments | 0.00 | 0.00 | |
| CashAndCashEquivalents | 66.14K | 15.42K | 2.82M |
| Line Item | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|
| FreeCashFlow | -2.19M | -818.77K | -593.70K |
| RepurchaseOfCapitalStock | -36.23M | -36.00M | |
| RepaymentOfDebt | -40.00K | -1.20M | -180.77K |
| IssuanceOfDebt | 2.60M | 0.00 | 1.25M |
| IssuanceOfCapitalStock | 0.00 | 73.13M | 3.65M |
| CapitalExpenditure | -16.32K | -77.39K | |
| IncomeTaxPaidSupplementalData | 461.96K | 0.00 | |
| EndCashPosition | 66.14K | 15.42K | 2.82M |
| BeginningCashPosition | 15.42K | 124.50K | 349.27K |
| EffectOfExchangeRateChanges | -31.05K | -20.79K | |
| ChangesInCash | 50.72K | -109.08K | 2.49M |
| FinancingCashFlow | -33.67M | 34.54M | 4.72M |
| CashFlowFromContinuingFinancingActivities | -33.67M | 34.54M | 4.72M |
| NetOtherFinancingCharges | -1.39M | ||
| NetCommonStockIssuance | -36.23M | 37.13M | 3.65M |
| CommonStockPayments | -36.23M | -36.00M | |
| CommonStockIssuance | 0.00 | 73.13M | 3.65M |
| NetIssuancePaymentsOfDebt | 2.56M | -1.20M | 1.07M |
| NetShortTermDebtIssuance | 2.56M | -1.20M | 0.00 |
| ShortTermDebtPayments | -40.00K | -1.20M | 0.00 |
| ShortTermDebtIssuance | 2.60M | 0.00 | 0.00 |
| NetLongTermDebtIssuance | 634.06K | 1.07M | |
| LongTermDebtPayments | -485.80K | -180.77K | |
| LongTermDebtIssuance | 1.12M | 1.25M | |
| InvestingCashFlow | 35.91M | -33.83M | -1.71M |
| CashFlowFromContinuingInvestingActivities | 35.91M | -33.83M | -1.71M |
| NetOtherInvestingChanges | -300.00K | -70.21M | |
| InterestReceivedCFI | 455.66K | 561.96K | |
| NetInvestmentPurchaseAndSale | 35.75M | 35.82M | -3.42M |
| SaleOfInvestment | 36.23M | 36.00M | |
| PurchaseOfInvestment | -480.00K | -180.00K | -3.42M |
| NetBusinessPurchaseAndSale | 0.00 | 1.78M | |
| SaleOfBusiness | 0.00 | 1.78M | |
| NetIntangiblesPurchaseAndSale | -7.44K | 0.00 | |
| PurchaseOfIntangibles | -7.44K | 0.00 | |
| NetPPEPurchaseAndSale | -5.50K | -77.39K | |
| SaleOfPPE | 3.38K | 0.00 | |
| PurchaseOfPPE | -8.87K | -77.39K | |
| OperatingCashFlow | -2.19M | -818.77K | -516.31K |
| CashFlowFromContinuingOperatingActivities | -2.19M | -818.77K | -516.31K |
| TaxesRefundPaid | -13.93K | 145.19K | |
| InterestReceivedCFO | 33.63K | 625.51 | |
| InterestPaidCFO | -48.89K | -11.30K | |
| ChangeInWorkingCapital | 1.67M | 1.55M | 134.17K |
| ChangeInOtherCurrentLiabilities | -27.01K | 39.75K | |
| ChangeInOtherCurrentAssets | -52.68K | -5.53K | |
| ChangeInPayablesAndAccruedExpense | 1.76M | 1.56M | 95.81K |
| ChangeInPayable | 1.76M | 1.56M | 95.81K |
| ChangeInAccountPayable | 1.80M | 1.04M | |
| ChangeInTaxPayable | -45.04K | 524.56K | |
| ChangeInIncomeTaxPayable | -45.04K | 524.56K | |
| ChangeInPrepaidAssets | -82.06K | -7.21K | |
| ChangeInInventory | -331.76K | 0.00 | |
| ChangeInReceivables | -745.19K | 4.13K | |
| OtherNonCashItems | -1.45M | -2.78M | 11.92K |
| ProvisionandWriteOffofAssets | 25.55K | 0.00 | |
| AssetImpairmentCharge | 312.22K | 77.39K | |
| DeferredTax | 2.54K | -145.16K | |
| DeferredIncomeTax | 2.54K | -145.16K | |
| DepreciationAmortizationDepletion | 9.71M | 23.25K | |
| DepreciationAndAmortization | 9.71M | 23.25K | |
| AmortizationCashFlow | 9.64M | 0.00 | |
| AmortizationOfIntangibles | 9.64M | 0.00 | |
| Depreciation | 77.08K | 23.25K | |
| OperatingGainsLosses | 145.65K | -1.82M | |
| PensionAndEmployeeBenefitExpense | 71.18K | 0.00 | |
| NetForeignCurrencyExchangeGainLoss | 75.53K | 8.56K | |
| GainLossOnSaleOfPPE | -1.06K | 0.00 | |
| NetIncomeFromContinuingOperations | -2.41M | 403.78K | 1.06M |
SEC Filings
Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.
Public Trades for OSRH
| Date | User | Asset | Broker | Type | Position Size | Entry Price | Patterns |
|---|